Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 398 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: hemoglobin A1c Clear all

Conditions: Obstructive Sleep Apnea, Diabetes Mellitus
Interventions: PreDx Diabetes Risk Score; Behavioral
Lead sponsor: Mike O'Callaghan Military Hospital; Federal
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Overweight and Obesity, Type 2 Diabetes Mellitus
Interventions: Water, Glucose, Steviol Glycosides, Steviol Glycosides plus glucose, Rebaudioside A; Other
Lead sponsor: Midwest Center for Metabolic and Cardiovascular Research; Other
Eligibility: 18 Years to 50 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Miami Gardens, Florida • Naples, Florida • Chicago, Illinois

Conditions: Atherosclerosis, Type 2 Diabetes (T2D)
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 279 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Gastric Bypass Surgery, Obesity
Interventions: gastric bypass surgery, Diet induced weight loss; Procedure · Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Hemorrhagic Stroke
Interventions: In-patient and out-patient electronic health record alert; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes
Interventions: Nutralin; Dietary Supplement
Lead sponsor: Avera McKennan Hospital & University Health Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy
Interventions: Not listed
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Santa Barbara, California • College Station, Texas

Conditions: Diabetes
Interventions: A1c, Self-collection, Blood sample; Device
Lead sponsor: Home Access Health Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 2
States / cities: San Mateo, California • Louisville, Kentucky

Conditions: Type 2 Diabetes
Interventions: Pharmacist Only, Continuous Glucose Monitor (CGM), Community Health Worker (CHW); Behavioral · Device
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 25 Years to 75 Years
Enrollment: 318 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
Interventions: hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 79 Years
Enrollment: 7,287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 4
States / cities: Minneapolis, Minnesota • Winston-Salem, North Carolina • Cleveland, Ohio + 1 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Canagliflozin, Placebo, Sitagliptin; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 678 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 24
States / cities: Phoenix, Arizona • Concord, California • Greenbrae, California + 21 more

Conditions: Prediabetes
Interventions: Stelo CGM; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Virtual Clinic; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Diabetes Mellitus
Interventions: HBA1c data and glucose levels; Diagnostic Test
Lead sponsor: Abbott Diabetes Care; Industry
Eligibility: 4 Years and older
Enrollment: 488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Miami Gardens, Florida • Idaho Falls, Idaho • Billings, Montana + 5 more

Conditions: Diabetes Mellitus, Type 2, Cancer
Interventions: Nurse-led diabetes care; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Diabetes, Gestational, PreDiabetes, Diabetes Mellitus, Type 2
Interventions: Metformin; Drug
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes Mellitus, Obesity
Interventions: Lifestyle Modification; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes Mellitus, Type 2
Interventions: Monthly Unconditional Financial Incentive, Weekly Food Purchasing Financial Incentive, Glycemic Control Financial Incentive, Diabetes Education; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: canagliflozin, Placebo (for canagliflozin); Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 20 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Behavior, Health
Interventions: Pre-visit and post-visit patient messaging, Default pended order, EHR communication; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 16,416 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes Mellitus
Interventions: Alternate site blood glucose testing; Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Glucose Intolerance, Glucose Metabolism Disorders (Including Diabetes Mellitus)
Interventions: Almond, Control; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Inflammation
Interventions: Influenza Virus Vaccine; Biological
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2015
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Type 2 Diabetes, Overweight, Obesity
Interventions: Weight Watchers modified program, Standard Care group; Behavioral · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 563 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 15
States / cities: Birmingham, Alabama • La Jolla, California • Augusta, Georgia + 11 more

Search by objective public record fields.

Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea

A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Mechanisms of Diabetes Control After Weight Loss Surgery

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin

Models of Nutrition From Continuous Glucose Monitors

Comparison Study of Lay Person Finger Stick Versus Blood Draw

A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring

Intensive Glycemic Control and Skeletal Health Study

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Trial of CGM Technology in Persons Living With Prediabetes

Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose Monitoring

HbA1c Variation Study

Pilot RCT Feasibility Study: Cancer and T2D

A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes

A Trial of Two Diets for Weight and Diabetes Management

Lowering Food Insecurity and Improving Diabetes With Financial Incentives

CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes

Preventive Reminder Ordering AssistanCe Via Texting for Improved Visit Encounters

Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control

Effects of Almonds on Glycemia in Adults With Elevated Hemoglobin A1c Concentrations

Vaccine Efficacy in Diabetic and Elderly Patients

Weight Loss Study for People With Type 2 Diabetes